Archive

The GIBS October Health Workplace Well-being report reveals the state of employee mental health and the impact of workplace environments.

In 2023, the global wellness industry reached a remarkable $6.32 trillion valuation, surpassing the combined size of the sports and pharmaceutical industries. This figure, reported by the Global Wellness Institute (GWI), marks a 25% growth since 2019, driven by a surge in demand for health-focused products and services post-pandemic. The GWI defines wellness as “the […]

The Department of Health and National Treasury are exploring using the R2.3-trillion savings pool, managed by the PIC, to fund health infrastructure upgrades.

South Africa’s health budget 2024 under scrutiny after Minister’s statement, sparking concerns among activists and unions.

New Zealand customs has seized semaglutide-based drugs made in Bangladesh, underscoring a rise in global demand for cheaper alternatives to Ozempic.

In 2023, tuberculosis was the top infectious disease killer worldwide, with 1.25 million deaths. SA’s TB incidence is declining, but fatalities remain high.

Finance Minister Enoch Godongwana attributes the staffing crisis in SA’s healthcare services to provinces mismanaging Treasury funds intended for wages.

Find out about groundbreaking AI innovations presented by tech giants aimed at improving healthcare delivery and efficiency.

South Africa’s two largest pharmacy chains, Clicks and Dis-Chem, are pushing aggressive expansion plans, reflecting market optimism about their future growth.

Aspen Pharmacare has secured a licensing agreement to enter the GLP-1 agonist market, positioning it for growth in diabetes and obesity treatment solutions.

The rise in TB cases underscores the challenges in global eradication efforts as the disease was the leading cause of infectious disease-related deaths in 2023.